Medical intelligent low-temperature rapid hemostatic forceps

By combining medical intelligent low-temperature rapid hemostatic forceps with low-temperature plasma and intelligent control system, the shortcomings of traditional hemostasis methods are solved, and a rapid and safe hemostasis effect is achieved, which is suitable for different treatment needs.

CN120605087APending Publication Date: 2025-09-09YIZHENG PEOPLES HOSPITAL
10 Cites 0 Cited by

Patent Information

Application Number
CN202510636982.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-05-18
Publication Date
2025-09-09

AI Technical Summary

Technical Problem

Existing hemostasis methods have shortcomings in terms of speed, accuracy and safety, especially traditional compression hemostasis has low efficiency, electrocoagulation hemostasis has the risk of thermal damage, the operation is complicated and is not suitable for emergency or minimally invasive surgery.

Method used

It uses medical intelligent low-temperature rapid hemostatic forceps, combined with low-temperature plasma technology and intelligent control system, to achieve rapid and accurate hemostasis through replaceable electrodes and real-time temperature monitoring.

Benefits of technology

It achieves rapid hemostasis, reduces operation time and patient bleeding volume, reduces the risk of damage to surrounding tissues, and improves the safety and controllability of the operation.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention discloses a pair of medical intelligent low-temperature rapid hemostatic forceps which comprises a forceps body, electrodes, a cooling module and a control box, rapid hemostasis is achieved through a low-temperature plasma technology, the electrodes generate low-temperature plasmas through current conduction, pathological tissues are rapidly decomposed, and bleeding is stopped. The cooling module and the electrodes cooperate to adjust the temperature of the treatment area in real time, and damage to normal tissue caused by overheating is avoided. The electrodes can be replaced, different treatment requirements are met, and a more flexible operation mode is provided. The method has the main beneficial effects that the hemostasis efficiency is remarkably improved, the treatment time and the intraoperative bleeding amount are reduced through a low-temperature plasma technology, the safety is better, the possible damage to normal tissues in a traditional method is avoided, the operation is convenient and fast, the treatment process is controlled in real time, and the method is widely suitable for hemostasis requirements in various medical operations.
Need to check novelty before this filing date? Find Prior Art